focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Morning El...positive chart analysis and a move to 4.25p would put most into profit since the high, next level at 6.5p creates a new year high and imo should be reached if no large adverse sales. Need one more good news byte imo to continue momentum then if revenues flow the ship will be sailing. New BOD doing a good job so far.
Afternoon folks, Botak reminded us below of the exclusive distribution agreement signed last July for Boya Industries in China to supply research versions of TexRAD Lung to medical centres in China on behalf of GE. This now appears a very good strategic move as it prepares the ground for a future rollout of the clinical version by GE, perhaps not too long after the India contract. Smoking, and by definition lung cancer, rates are very high in China so this must be a huge market for TexRAD assistance. Would love to ascribe figures but massive would not be an overstatement imo. One to keep an eye on, might happen this year and it�s effect on the sp would be very positive. All imo and dyor.
Hi John, impossible to predict effect on sp. The potential is so huge, detailed a couple of weeks ago by Elartu on this B.B. There could be a couple more JVs announced and any of these could be for any country, if you look at India, China, Korea, Japan, Europe inc. UK you begin to see how vast the market is, Add on to that we only have CE mark for TexRAD Lung at present, but there are many many more to be developed AR intimated that Liver should follow this summer. Then there is the Cadran side of the business which has just renewed its contract with Papworth Hospital, and this has big growth potential. This is why I firmly believe FDBK to be very undervalued and there is now a very competent BOD to drive the business forward. Once revenues start to hit the balance sheet this company will be transformed and no longer labelled �micro� imo.
Afternoon all, buys showing as sells just had a little top up @ 2.80, less than the chunky 440k buy earlier. Prices all over the place, are mms short? Again volume very high, augers well for next week, wouldn�t want to be short on this if any more news lands in the next few days.
Can�t complain about the volume El but these late reported trades can cause real distortion and at this size the market is clearly false for a period. What is your view El, were mms caught hopping and was the 2m sell from TB? Can�t call tomorrow from all this.
Morning all, most of the reds shown today look like buys apart from the �150k around 10.48. So buys easily outnumbering sales yet the mms have lowered the sp by 11%. Perhaps without TB selling they are now short of stock and trying to encourage short term profit takers. I agree with other comments that there may be further good news coming. Current sp does not reflect potential at all, could easily be 5-7p year end and 10p in 12 months imo, perhaps even that is conservative if JVs produce real income, Liver gets CE, and FDBK moves to profitability. Keep the faith, ignore mm manipulation would be my advice.
Evening Hors and yes this has been a very rocky road to travel. I am sure El and Botak are also very relieved today to see commercial success, and this should just be the beginning. I am now very confident of considerable success for Lung with revenues to match, then we will have Liver CE marked and others next year. All to be used underlicence on major manufacturer scanners. The revenue stream should be very exciting in a year or two, and the sp will follow. Well done to all lths for holding out, we deserve to reap the benefits.
Good summary Botak, it feels like a real commercial operation now rather than a company with no clear direction. Be interesting to see the next set of figures and particularly comments regarding JVs and status in China, India etc. At some point FDBK has to get to break even and can then begin real growth as TexRAD gets taken up clinically. Future looking brighter than for some time, got to make up lost ground now.
Very interesting El in that it highlights the unusual situation of a tiny micro cap company now having a BOD drawn from industry giants. You would think as they have put their own cash into buying shares, and in some cases deferred salary in favour of share options, that they believe FDBK to be a golden goose. Certainly shows confidence, what does my mate Botak make of it all? Totally different feel compared to couple of months ago imo.
You will have to help me out here El, are mms trying to buy ahead of expected news or has the overhang all but gone now? Hopefully an interesting week next week, be nice to get back above 2p, still cheap at that price imo. Have a good weekend.
Morning Hors, El hope the sun is to your liking. Agree the BOD is very impressive with strong commercial emphasis. Ties to Siemens, GE, Philips would get this moving. Would be good to see clinical sales of Lung producing revenue in the next results. Would like to know how sales discussions are going in China, S Korea, India,Japan these would be massive markets. Also hoping for Liver to be CE marked by next results? Get all this together and we would be the right side of 5p at last, best of luck to all lths.
Liked the bit early on where AR confirmed the company was now well positioned for growth over the next 6-12 months. Should see real evidence of that then by the year end? Also the emphasis on JVs, be very interesting to see what happens there, but no mention of geographic concentration which would have been nice. Keeps the pot boiling though.
Afternoon Hors, El...feels a bit more optimistic doesn�t it? Volumes back to the heady 4-5p sp days so once the overhang is done the sp must bounce. If we get the clinical sales, JVs, positive trial results etc could we dream of a shortage of shares in the market if TB doesn�t offload any? Credit to DC and the BOD over the last couple of months they may have positioned FDBK perfectly for lift off....let us hope so.
I think so FF. When China is in production it locks in sustainable cashflow and if replicated in Korea, Japan, USA etc then the company is transformed. Other international majors will be placing very large orders over the next 1-3 years and though the order value per kilo will decrease the total output for VRS in a year or two could be enormous. So yes imo the current sp does not reflect anything like the future, a multi multi bagger beckons. All imo so dyor.
Looking and lurking my friend. Good to see any upward move for a change but still a long way off even 2p which would have been considered derisory 6 months ago. There does seem to be a positive feel around the share now though and I might well go back in if the current trend holds, from a long term view any buy under 2p would seem a bargain so no rush at the moment. I do like the new appointments and the performance related structure, looking good imo.
Wow Botak, all or nothing eh? Valid rant about many on AIM the only surprise is the minuscule number of prosecutions given the blatant fraud in some cases. Agree though that FDBK is not of that ilk, they deserve a bit of fortune for the development of what could be life enhancing software and like you I hope the sp takes a turn for the better soon. Ridiculous to think it has got to where it is after the CE was obtained, we all, thought it would be heading for double figs by now, loss of a year really. I will wait to the end of this year before making a decision, I do believe by then Mr Crabb will have made progress.